SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
Position in FDMT — 4D Molecular Therapeutics, Inc.
CIK 1446179
BALA CYNWYD, PA
Position in FDMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$148,228
New position
Shares Held
11,145
first reported quarter
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#110
of 158 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC holds $18,967,826 across 42 Biotechnology names. FDMT ranks #32 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
91,886 | $5,257,716 | |
| 2 | NKTR |
Nektar Therapeutics
|
20,177 | $1,408,556 | |
| 3 | QURE |
uniQure N.V.
|
15,042 | $692,834 | |
| 4 | OLMA |
Olema Pharmaceuticals, Inc.
|
55,121 | $689,563 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
16,620 | $648,346 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
|
37,663 | $637,257 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
17,322 | $630,694 | |
| 8 | IMNM |
Immunome Inc.
|
26,035 | $551,681 |
All Filings in FDMT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $148,228 | 11,145 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||